Amyris, Inc. (AMRS)
| Market Cap | 725.75M |
| Revenue (ttm) | 222.67M |
| Net Income (ttm) | -87.32M |
| Shares Out | 319.71M |
| EPS (ttm) | -0.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,759,940 |
| Open | 2.20 |
| Previous Close | 2.15 |
| Day's Range | 2.12 - 2.32 |
| 52-Week Range | 1.47 - 17.19 |
| Beta | 1.66 |
| Analysts | Buy |
| Price Target | 12.00 (+428.6%) |
| Earnings Date | Aug 4, 2022 |
About AMRS
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company ... [Read more...]
Financial Performance
In 2021, Amyris's revenue was $341.82 million, an increase of 97.43% compared to the previous year's $173.14 million. Losses were -$270.97 million, -18.15% less than in 2020.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for AMRS stock is "Buy." The 12-month stock price forecast is 12, which is an increase of 428.63% from the latest price.
News
3 Short Squeeze Penny Stocks To Watch Before Next Week
Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Tech Stocks at the Top of Our Watchlists
This basket of infrastructure software, technical instrument, and specialty chemicals stocks looks like a good value.
AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION
EMERYVILLE, Calif. , June 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...
AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE
EMERYVILLE, Calif. , June 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...
3 Stocks Wall Street Thinks Could Triple Your Money or Better
Find out why the pros think these stocks could gain 200% or better.
AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022
EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...
AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES
EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...
Better Buy: Gingko Bioworks vs. Amyris
Which of these fallen stocks has the best chance of recovery?
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Record consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 EMERYVILLE, Calif. , May 10, 2022 /PRNewswire/ --...
AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10
EMERYVILLE, Calif. , May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-...
New Strong Sell Stocks for May 2nd
ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022
AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT
EMERYVILLE, Calif. , April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...
AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT
EMERYVILLE, Calif. , April 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...
3 Top U.S. Stocks to Watch in April
Keep your eyes focused on these red, white, and blue businesses over the coming weeks?
New Strong Sell Stocks for March 24th
GHM, AMRS, and GDOT have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2022
Will These Penny Stocks Explode in April? 3 to Watch This Week
Which penny stocks are you watching in April? The post Will These Penny Stocks Explode in April?
AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK
EMERYVILLE, Calif. , March 17, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know
Amyris, Inc. (AMRS) closed at $3.96 in the latest trading session, marking a +1.02% move from the prior day.
AMYRIS CLOSES ACQUISITION OF MENOLABS
EMERYVILLE, Calif. , March 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...
Amyris (AMRS) Q4 Earnings Lag Estimates, Sales Fall Y/Y
Amyris (AMRS) sees strong revenues in its consumer segment in Q4 driven by the accelerated growth of its consumer brands.
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
EMERYVILLE, Calif., March 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...
AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE
EMERYVILLE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...
AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1
EMERYVILLE, Calif. , Feb. 22, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...